Vaxart Stock Price. Everything You Need To Know About The Vaxart Stock! Vaxart Stock Price. Everything You Need To Know About The Vaxart Stock!


Vaxart, Inc. is a clinical-stage biotechnology company that is focused on developing oral recombinant vaccines using its innovative Vector-Adjuvant-Antigen Standardized Technology (VAAST) oral vaccine platform. With its headquarters in South San Francisco, California and 164 full-time employees, Vaxart is committed to advancing its product pipeline, which includes vaccine candidates designed to protect against norovirus, coronavirus, seasonal influenza, and respiratory syncytial virus (RSV).

The company’s norovirus vaccine is an oral tablet vaccine candidate that protects against both norovirus GI and norovirus GII. By targeting the norovirus GI.1 Norwalk strain and the norovirus GII.4 Sydney strain, this innovative vaccine offers a promising approach to fighting norovirus infection.

In addition to its norovirus vaccine, Vaxart is also developing an influenza vaccine that is currently in Phase II clinical trials for the treatment of H1 influenza infection. The company is also working on a respiratory syncytial virus vaccine and a coronavirus vaccine, which is in Phase II clinical trials for the treatment of SARS-CoV-2 infection.

As investors consider the potential of Vaxart, it’s important to keep track of stock movements and stock price today, as well as premarket trends. While we cannot provide specific stock price information or market cap figures, it’s important to stay informed about the company’s performance and industry news. As with any investment opportunity, conducting thorough research and consulting with a financial advisor is crucial to making informed decisions.



Vaxart Stock Price. Everything You Need To Know About The Vaxart Stock! performance

  • Employees

    164
  • Company HQ

    South San Francisco
  • Website

    https://vaxart.com/
  • VXRT Asset Type

    Common Stock
  • VXRT Market Capitalization

    213.9M
  • Earnings Per Share -0.57
  • Dividends Per Share None
  • Dividend Date 2018-02-14
  • Quarterly Earnings Growth 0

Are you a retail investor from Malaysia, Thailand, Indonesia, or Vietnam looking to invest in the stock market? Look no further than Vaxart! As an investment platform, Zorion provides you with the opportunity to invest in real US stocks and Pre-IPO companies such as Vaxart. But how can you invest in this promising stock from Southeast Asia? To start investing in Vaxart from Malaysia, Thailand, Indonesia, or Vietnam, all you need is a Zorion account. Sign up today to gain access to investment insights and recommendations that will help you make informed decisions. We understand the importance of education when it comes to investing, which is why we also provide resources and educational materials to further enhance your investment knowledge. Don’t miss out on the chance to invest in Vaxart and other exciting stocks. Start your investment journey with Zorion and empower yourself with the tools and information you need to succeed.


Want To Buy Vaxart Stock From Malaysia, Indonesia, Thailand or Philippines? You may also be interested in: